持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/27 | 4,070 | 4,125 | 4,055 | 4,060 | +35 | +0.9% | 36,500 |
2019/08/26 | 4,015 | 4,070 | 4,010 | 4,025 | -120 | -2.9% | 71,500 |
2019/08/23 | 4,115 | 4,160 | 4,070 | 4,145 | +40 | +1% | 46,400 |
2019/08/22 | 4,180 | 4,180 | 4,085 | 4,105 | -65 | -1.6% | 53,900 |
2019/08/21 | 4,190 | 4,215 | 4,150 | 4,170 | -85 | -2% | 35,400 |
2019/08/20 | 4,205 | 4,255 | 4,175 | 4,255 | +50 | +1.2% | 34,400 |
2019/08/19 | 4,255 | 4,255 | 4,190 | 4,205 | -5 | -0.1% | 24,500 |
2019/08/16 | 4,195 | 4,240 | 4,170 | 4,210 | +15 | +0.4% | 43,000 |
2019/08/15 | 4,190 | 4,195 | 4,150 | 4,195 | -65 | -1.5% | 44,600 |
2019/08/14 | 4,255 | 4,300 | 4,220 | 4,260 | +15 | +0.4% | 42,000 |
2019/08/13 | 4,255 | 4,280 | 4,215 | 4,245 | -70 | -1.6% | 40,600 |
2019/08/09 | 4,330 | 4,385 | 4,305 | 4,315 | +20 | +0.5% | 33,500 |
2019/08/08 | 4,325 | 4,325 | 4,265 | 4,295 | -30 | -0.7% | 41,100 |
2019/08/07 | 4,330 | 4,355 | 4,290 | 4,325 | -50 | -1.1% | 62,200 |
2019/08/06 | 4,335 | 4,375 | 4,285 | 4,375 | -80 | -1.8% | 69,300 |
2019/08/05 | 4,430 | 4,520 | 4,370 | 4,455 | -175 | -3.8% | 93,900 |
2019/08/02 | 4,540 | 4,675 | 4,530 | 4,630 | +40 | +0.9% | 110,000 |
2019/08/01 | 4,590 | 4,595 | 4,520 | 4,590 | +5 | +0.1% | 50,200 |
2019/07/31 | 4,545 | 4,625 | 4,540 | 4,585 | -15 | -0.3% | 61,200 |
2019/07/30 | 4,590 | 4,605 | 4,545 | 4,600 | ±0 | ±0% | 61,000 |
2019/07/29 | 4,675 | 4,675 | 4,555 | 4,600 | -55 | -1.2% | 34,500 |
2019/07/26 | 4,700 | 4,700 | 4,635 | 4,655 | +5 | +0.1% | 45,900 |
2019/07/25 | 4,655 | 4,670 | 4,625 | 4,650 | ±0 | ±0% | 44,800 |
2019/07/24 | 4,675 | 4,675 | 4,615 | 4,650 | -15 | -0.3% | 57,800 |
2019/07/23 | 4,650 | 4,685 | 4,620 | 4,665 | ±0 | ±0% | 39,500 |
2019/07/22 | 4,675 | 4,740 | 4,650 | 4,665 | -50 | -1.1% | 44,600 |
2019/07/19 | 4,620 | 4,720 | 4,610 | 4,715 | +95 | +2.1% | 48,600 |
2019/07/18 | 4,735 | 4,735 | 4,605 | 4,620 | -145 | -3% | 59,800 |
2019/07/17 | 4,730 | 4,785 | 4,720 | 4,765 | +25 | +0.5% | 39,200 |
2019/07/16 | 4,735 | 4,760 | 4,710 | 4,740 | -45 | -0.9% | 32,400 |
2019/07/12 | 4,765 | 4,790 | 4,715 | 4,785 | -5 | -0.1% | 30,400 |
2019/07/11 | 4,735 | 4,820 | 4,735 | 4,790 | +85 | +1.8% | 50,200 |
2019/07/10 | 4,680 | 4,720 | 4,635 | 4,705 | +5 | +0.1% | 53,800 |
2019/07/09 | 4,785 | 4,805 | 4,685 | 4,700 | -50 | -1.1% | 48,800 |
2019/07/08 | 4,830 | 4,835 | 4,745 | 4,750 | -100 | -2.1% | 41,800 |
2019/07/05 | 4,925 | 4,925 | 4,815 | 4,850 | -40 | -0.8% | 28,400 |
2019/07/04 | 4,880 | 4,940 | 4,850 | 4,890 | +50 | +1% | 31,800 |
2019/07/03 | 4,830 | 4,910 | 4,830 | 4,840 | -35 | -0.7% | 58,500 |
2019/07/02 | 4,800 | 4,890 | 4,795 | 4,875 | +115 | +2.4% | 47,100 |
2019/07/01 | 4,670 | 4,775 | 4,665 | 4,760 | +175 | +3.8% | 56,700 |
2019/06/28 | 4,680 | 4,700 | 4,565 | 4,585 | -50 | -1.1% | 63,400 |
2019/06/27 | 4,655 | 4,655 | 4,595 | 4,635 | -10 | -0.2% | 42,200 |
2019/06/26 | 4,710 | 4,725 | 4,640 | 4,645 | -60 | -1.3% | 52,000 |
2019/06/25 | 4,735 | 4,800 | 4,705 | 4,705 | -40 | -0.8% | 46,700 |
2019/06/24 | 4,630 | 4,760 | 4,630 | 4,745 | +130 | +2.8% | 51,900 |
2019/06/21 | 4,750 | 4,750 | 4,610 | 4,615 | -150 | -3.1% | 98,000 |
2019/06/20 | 4,775 | 4,835 | 4,765 | 4,765 | ±0 | ±0% | 48,500 |
2019/06/19 | 4,745 | 4,780 | 4,720 | 4,765 | +40 | +0.8% | 84,600 |
2019/06/18 | 4,750 | 4,825 | 4,725 | 4,725 | -15 | -0.3% | 52,900 |
2019/06/17 | 4,785 | 4,820 | 4,735 | 4,740 | -80 | -1.7% | 40,300 |
1401~
1450
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 293,900円 | +5.1% | -7.0% | 2.72% | 19.30倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 214,300円 | +3.1% | -6.5% | 2.24% | 9.95倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 145,800円 | -2.4% | -52.3% | 3.91% | 17.45倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 201,200円 | +4.1% | -3.1% | 2.88% | 17.65倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム